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http://dx.doi.org/10.1016/j.ccell.2014.09.002SUMMARYSnail is primarily known as a transcriptional repressor that induces epithelial-mesenchymal transition by
suppressing adherent proteins. Emerging evidence suggests that Snail can act as an activator; however,
the mechanism and biological significance are unclear. Here, we found that CREB-binding protein (CBP) is
the critical factor in Snail-mediated target gene transactivation. CBP interacts with Snail and acetylates
Snail at lysine 146 and lysine 187, which prevents the repressor complex formation. We further identified
several Snail-activated targets, including TNF-a, which is also the upstream signal for Snail acetylation,
and CCL2 and CCL5, which promote the recruitment of tumor-associated macrophages. Here, we present
our results on the mechanism by which Snail induces target gene transactivation to remodel the tumor
microenvironment.INTRODUCTION
For tumors to metastasize, the cancer cells must gain enhanced
migratory and tumor-initiating capacity, and the tumor microen-
vironment must be remodeled. During the metastatic process,
the epithelial-mesenchymal transition (EMT) is the crucial mech-
anism by which cancer cells are reprogrammed to possess
migratory and tumor-initiating capacity (Mani et al., 2008; De
Craene and Berx, 2013). In addition to the canonical effects of
EMT, increasing studies indicate that EMT has pleiotropic roles
in cancer metastasis, including overriding oncogene-induced
senescence (Ansieau et al., 2008), promoting invadopodia for-
mation (Eckert et al., 2011), facilitating single-cell movementSignificance
The understanding of Snail as an activator is relatively limited,
we identify themechanism that guides the activity of Snail throu
is, therefore, elucidated; ‘‘repressor Snail’’ inhibits adherent pr
tion of epithelial cancer cells, whereas ‘‘activator Snail’’ indu
expression to remodel the tumormicroenvironment. The parac
plaining the pivotal role of these stem-like cancer cells in host
534 Cancer Cell 26, 534–548, October 13, 2014 ª2014 Elsevier Inc.(Yang et al., 2012), and directing symmetric cell division (Hwang
et al., 2014). However, it is largely unknown whether the cancer
cells undergoing EMT are able to modulate the tumor microenvi-
ronment and what the role of EMT is in the interplay between
tumor and host cells.
The EMT regulator Snail is a zinc finger transcription factor that
is largely a transcriptional repressor. In cancer metastasis, Snail
induces EMT by repressing E-cadherin expression (Cano et al.,
2000). Mechanistically, Snail represses CDH1 transcription by
recruiting corepressors to the CDH1 promoter and by modi-
fying the chromatin, thereby promoting transcriptional silencing.
The reported corepressor complexes of Snail include HDAC1/
HDAC2/Sin3A for histone deacetylation (Peinado et al., 2004),compared with the knowledge of Snail as a repressor. Here,
gh the acetylation of Snail. The ‘‘yin and yang’’ effect of Snail
otein expression to promote the disaggregation and migra-
ces mesenchymal proteins to complete EMT and cytokine
rine effect of cells undergoing EMT has been highlighted, ex-
-cancer interplay.
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Figure 1. Snail Interacts with CBP/p300 to Activate Target Gene Transcription
(A) Quantitative ChIP for analyzing the enrichments of H3K18Ac (upper panel), H4R3me2 (middle panel), and H3K27me3 (lower panel) on the promoter of ERCC1,
IL8, and CDH1 in FaDu cells transfected with Snail (FaDu-Snail) or a control vector (FaDu-CDH). Data represent means ± SEM. *p < 0.05; **p < 0.01.
(B) Quantitative real-time PCR for confirming the knockdown efficiency of the acetyltransferases (CBP,PCAF, p300, andGCN5) and the expression of Snail target
genes (ERCC1 and IL8) in FaDu-CDH, FaDu-Snail, and FaDu-Snail receiving shRNA against different acetyltransferases or a control vector (pLKO). Data
represent means ± SEM. *p < 0.05.
(C) Immunoprecipitation (IP)-western blot for detecting the association of endogenous Snail and different acetyltransferases in a head and neck cancer cell line
OECM-1. IgG, immunoglobulin G.
(D) Immunoprecipitation-western blot for detecting the association between the ectopic CBP and Snail in 293T cells cotransfected with pHA-CBP and
pFLAG-Snail. IB, immunoblot.
(legend continued on next page)
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Snail Acetylation Promotes Macrophage Recruitmentpolycomb repressive complex for histone 3 lysine 27 trimethyla-
tion (H3K27me3) (Herranz et al., 2008), and PRMT5 for histone 4
arginine 3 dimethylation (H4R3me2) (Hou et al., 2008). Accumu-
lating evidence suggests that Snail could be a transcriptional
activator. Snail expression triggers euchromatin changes in
certain mesenchymal genes, thereby inducing EMT (Wu et al.,
2011; Javaid et al., 2013). In Drosophila, Snail potentiates acti-
vator-mediated target gene expression (Rembold et al., 2014).
Snail directly activates the transcription of ERCC1 and IL8
(Hsu et al., 2010; Hwang et al., 2011) and cooperates with p65
to induce the expression of fibronectin 1 (Stanisavljevic et al.,
2011). However, the mechanism and significance of Snail as
an activator are unclear. In this study, we aim to identify the
mechanism of Snail-induced target gene activation and its
biological significance for cancer progression.
RESULTS
CBP/p300 Interacts with Snail and Promotes
Transcriptional Activation of Snail Target Genes
The initial aim of this study was to investigate the mechanism of
Snail-induced target gene transactivation. We hypothesized
that histone marks surrounding the Snail-binding area of Snail-
activated genes would differ from those surrounding Snail-
repressed genes, resulting in the differential regulation of Snail
target genes. To this end, ERCC1 and IL8 were used as model
Snail-activated genes, and CDH1 was a model Snail-repressed
gene. Chromatin immunoprecipitation (ChIP) was performed
in FaDu cells, a head and neck cancer cell line, which stably ex-
pressed either a Snail vector (FaDu-Snail) or a control vector
(FaDu-CDH). The results showed that overexpression of Snail
enhanced histone acetylation, including histone 3 lysine 4 acet-
ylation (H3K4Ac), histone 3 lysine 14 acetylation (H3K14Ac),
and histone 3 lysine 18 acetylation (H3K18Ac) on the promoters
of ERCC1 and IL8. This enrichment of histone acetylation
was only observed on Snail-activated genes, not on CDH1.
Conversely, the reported Snail-associated repressive marks
on CDH1, specifically H3K27me3 and H4R3me2, were not en-
riched on Snail-activated genes (Figure 1A; Figure S1A available
online). A similar change in these histone marks was observed
when FaDu cells were treated with transforming growth factor
beta (TGFb), a known inducer of Snail expression and EMT (De
Craene and Berx, 2013) (Figure S1B). We next sought to uncover
the primary histone acetyltransferases (HATs) responsible for
Snail-induced target gene expression. To this end, we knocked
down different HATs in FaDu-Snail transfectants and observed
the effect on the expression of Snail-activated target genes. Of
the various HATs, knockdown of CREB-binding protein (CBP)
or p300 attenuated Snail-induced target gene expression to
the greatest extent (Figure 1B). Therefore, we hypothesized
that Snail recruits CBP/p300 to the promoter of activated target
genes as a coactivator. The coimmunoprecipitation experiment
showed that Snail was physically associated with CBP/p300(E) Sequential ChIP for analyzing the co-occupancy of Snail and CBP on the pro
secondary immunoprecipitation.
(F) Luciferase (luc) reporter assay. The 293T cells were cotransfected with the repo
different expression vectors as indicated. b-gal, b-galactosidase. Data represent
See also Figure S1.
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acids (aa) 60–90 (Figure S1C), and the CBP fragment aa 1101–
1679, which contains HAT domain, was responsible for the
CBP-Snail interaction (Figure S1D). Snail and CBP co-occupied
the promoter of ERCC1 and IL8 but less frequently occupied
the CDH1 promoter (Figure 1E). CBP significantly augmented
Snail-induced activation of target genes (Figure 1F). These re-
sults suggest that CBP/p300 interacts with Snail and that they
co-occupy the promoters of target genes to induce transcrip-
tional activation.
Snail Is Acetylated by CBP at Lysine 146 and Lysine 187
In addition to its role as a HAT (Berger, 2007), CBP/p300 has
been shown to acetylate interacting proteins to modulate their
function (Gu and Roeder, 1997; Ito et al., 2001). We investigated
whether CBP/p300 acetylates Snail. The ectopic expression of
CBP enriched Snail acetylation (Figure 2A). In Snail transfec-
tants, the knockdown of CBP/p300, but no other HATs, reduced
Snail acetylation (Figure 2B). Mass spectrometry analysis identi-
fied that lysine 146 and lysine 187 on the zinc finger domain of
Snail were acetylated by CBP (Figure 2C), and these two resi-
dues were highly conserved across species (Figure 2D). In vitro
acetylation assays confirmed the acetylation of lysine 146
and lysine 187 on Snail by a HAT (Figure 2E). Mutation of either
site attenuated CBP-induced Snail acetylation, and mutations
at both of these sites abrogated the acetylation (Figure 2F). A
proximity ligation assay (PLA) provided additional evidence to
support the acetylation of Snail by CBP (Figures S2A and S2B).
To further confirm CBP-induced Snail acetylation, we generated
antibodies to specifically recognize lysine 146- or lysine 187-
acetylated Snail (Figure S2C). Knocking downCBP, but not other
HATs, reduced lysine 146 or lysine 187 acetylation in the Snail
transfectants, as recognized by the antibodies (Figure S2D).
The expression of CBP increased Snail acetylation on lysine
146 and lysine 187, while mutation of either residue abrogated
the acetylation (Figure 2G). These data suggest that Snail is a
substrate for CBP-mediated acetylation.
Snail Acetylation Prevents the Assembly of the
Repressor Complex and Stabilizes Snail without
Affecting Its DNA-Binding Ability and Subcellular
Localization
Next, we investigated the effect of Snail acetylation on Snail-
mediated transcriptional activation. The inhibition of HAT
activity partially abrogates the transactivation of Snail-mediated
target genes (Figure S3A), suggesting that both the transcrip-
tional activity potential and HAT activity of CBP contribute to
Snail-induced target gene transcription. We further investigated
whether CBP and the corepressors were present in the same
complex. A coimmunoprecipitation experiment showed that
CBP and the corepressor Ajuba were not present in the
same complex (Figure 3A). Both an anti-CBP antibody and an
anti-Sin3A antibody were able to pull down Snail. However,moter of ERCC1, IL8, and CDH1 in FaDu-Snail cells. Data represent yields of
rter plasmid containing ERCC1 (pXP2-ERCC1) or IL8 (pXP2-IL8) promoter and
means ± SEM. *p < 0.05; **p < 0.01.
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Figure 2. Snail Is Acetylated by CBP at Lysine 146 and Lysine 187
(A) Immunoprecipitation (IP)-western blot for analyzing the acetylated Snail in 293T cells transfected with pFLAG-Snail with/without cotransfection of pHA-CBP.
IB, immunoblot.
(B) Immunoprecipitation-western blot for analyzing the acetylated Snail in FaDu-Snail transfectants receiving shRNA against different acetyltransferases or a
control vector (pLKO). b-actin was a loading control for immunoblots.
(C) Upper panel: mass spectrometry for determining the acetylation sites of Snail by analyzing the purified Snail proteins from 293T cells cotransfected with
GST-Snail and pHA-CBP. Lower panel: schematic representation of the acetylated sites on Snail.
(D) Alignment of Snail amino acids sequence among different species. Hs, Homo sapiens; Rn, Rattus norvegicus; Mm, Mus musculus; Bt, Bos taurus.
(legend continued on next page)
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Snail Acetylation Promotes Macrophage Recruitmentacetylated Snail was only present in the CBP-associated com-
plex, and HDAC1 and HDAC2 were found in the Sin3A-contain-
ing complex (Figure 3B). Ectopic CBP inhibited the interaction
between WT Snail and the corepressors (Ajuba, HDAC1, and
HDAC2) but had no effect on the interaction between the nona-
cetylatable Snail mutant (Snail2R) and corepressors (Figure 3C).
The corepressors Ajuba and Sin3A did not occupy the promoters
of Snail-activated genes (Figure 3D). Furthermore, a greater
enrichment of acetylated Snail was shown on the promoters of
Snail-activated genes than on CDH1 (Figure 3E). Because the
HDAC1/HDAC2/Sin3A complex is critical for Snail-mediated
target gene repression (Peinado et al., 2004), we wondered
whether HDAC1/HDAC2 was able to deacetylate Snail to facili-
tate the formation of the repressor complex. Treatment with
the HDAC inhibitor trichostatin (TSA), but not the SIRT1 inhibitor
nicotinamide (NAM), enhanced Snail acetylation (Figure 3F). The
knockdown of either HDAC1 or HDAC2 increased Snail acetyla-
tion (Figure 3G). HDAC1 deacetylates Snail at lysine 146, and
HDAC2 deacetylates Snail at both lysine 146 and lysine 187
(Figure 3H).
Snail has been shown to activate FN1 expression through
cooperation with p65 (Stanisavljevic et al., 2011). To investigate
whether Snail acetylation is involved in this event, we examined
the expression of fibronectin in FaDu cells expressing Snail
(FaDu-Snail) or the Snail2Rmutant (FaDu-Snail2R). An upregula-
tion of FN1 was shown in FaDu-Snail, but not FaDu-Snail2R,
transfectants compared with the control cells (Figure S3B). Acet-
ylated Snail was associated with p65, while nonacetylatable
Snail mutant did not interact with p65 (Figures S3C and S3D).
Furthermore, p65, CBP, and Snail were present in the same
complex (Figure S3E). The acetylated Snail and p65 co-occupied
the promoter of FN1 (Figure S3F), and Snail and p65 synergisti-
cally activated the FN1 promoter (Figure S3G).
We next examined the impact of Snail acetylation on the sta-
bility, DNA-binding ability, and localization of Snail. GSK-3b
can phosphorylate Snail and promotes its polyubiquitination
and degradation (Zhou et al., 2004). Here, we show that the
wild-type (WT) Snail is more stable than the nonacetylatable
Snail2R mutant (Figures S3H and S3I). The acetylation of Snail
by CBP reduced its phosphorylation; however, CBP showed
no impact on either the phosphorylation or the acetylation of
the Snail2R mutant (Figure S3J). Snail2R is more prone to be
polyubiquitinated than WT Snail (Figure S3K). Inhibition of HAT
activity by C646 increased the polyubiquitination of WT Snail.
However, the polyubiquitination of Snail that has been mutated
in its GSK3b phosphorylation site (Snail6SA; Zhou et al., 2004)
was unaffected by C646 (Figure S3L). Snail acetylation affected
neither the DNA-binding ability nor the subcellular localization of
Snail (Figures S3M and S3N). Interestingly, the expression of
Snail2R in FaDu cells only induced a partial EMT. Repression(E) In vitro acetylation assay. The biotin-labeled peptides containing the sequen
replaced lysine 146/187 with arginine, were incubated with HAT and acetyl Co-A
(F) Immunoprecipitation-western blot for analyzing the acetylated Snail in 293T c
Snail), Snail aa 146 Lys-to-Arg mutation (p-FLAGSnail146R), Snail aa 187 Lys-to
Lys187 (pFLAG-Snail2R).
(G) Western blot using the antibody specifically recognizing lysine-146-acetylat
cotransfected with pHA-CBP and a WT or the acetylation site-mutated Snail exp
See also Figure S2.
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served in FaDu-Snail2R. However, less induction of the mesen-
chymal protein fibronectin was found in FaDu-Snail2R compared
with FaDu-Snail (Figures S3O and S3P). Collectively, our data
suggest that acetylated Snail is associated with coactivators,
while nonacetylated Snail interacts with corepressors. Snail
acetylation increases the stability of Snail without affecting its
DNA-binding ability and subcellular localization.
TNF-a-IKKa Is Upstream of Snail Acetylation
Under tumor necrosis factor alpha (TNF-a) stimulation, CBP is
phosphorylated by IkB kinase (IKK)a at serine 1382 and serine
1386 to increase its acetyltransferase activity (Huang et al.,
2007). We investigated whether TNF-a can serve as an external
stimulus for increasing Snail acetylation and activity through
IKKa-CBP. First, we examined the impact of CBP phosphoryla-
tion on Snail acetylation and activity. Although both phosphomi-
metic CBP (EE-CBP) and unphosphorylatable CBP (AA-CBP)
interacted with Snail (Figure 4A), EE-CBP had a higher ability
to promote Snail acetylation compared with AA-CBP (Figure 4B).
EE-CBP also augmented Snail-induced target gene transacti-
vation more prominently than did AA-CBP (Figure 4C). Next,
we investigated whether the TNF-a-IKKa axis is responsible for
this effect. Exogenous TNF-a increased Snail acetylation in
different types of cancer cells (Figure 4D). In FaDu cells, phos-
phorylated IKKa, phosphorylated CBP, and acetylated Snail
were correspondingly increased on TNF-a stimulation (Fig-
ure 4E). Murine TNF-a induced Snail acetylation in mouse em-
bryonic fibroblasts (MEFs) from IKKb- or IKKg-knockout (KO)
mice but not in MEFs from IKKa-KOmice (Figure 4F). Compared
with FaDu-control cells, TNF-a significantly upregulated ERCC1
and IL8 in FaDu-Snail but not in FaDu-Snail2R (Figure 4G). In
the colon cancer cell line HCT15, inhibiting either TNF-a (with
the TNF-a inhibitor TNFI or etanercept) or CBP activity (by
C646) abrogated Snail-induced target gene expression (Fig-
ure 4H). These data suggest that the TNF-a-IKKa-CBP pathway
increases Snail acetylation and activity.
TNFA,CCL2, andCCL5Are TargetGenes Transactivated
by Snail
We next investigated the global effect of Snail acetylation on
target gene expression. A complementary DNA (cDNA) microar-
ray showed that the expression profile was different between
FaDu-Snail and FaDu-Snail2R (Figure 5A; Table S1). Among
the differentially expressed genes, the immune response genes
were the most prominent group (Figure 5B). There were other
genes upregulated in FaDu-Snail but not in FaDu-Snail2R,
including the mesenchymal genes, such as FN1 (Figure S2F),
ZEB1, and THBS1 (Figure S4A). Here, we focused on cytokine
genes because the immune response genes are the majorce surrounding Snail lysine 146 (upper panel) and lysine 187 (lower panel), or
and then analyzed by dot blot.
ells cotransfected with pHA-CBP and a vector expressing WT Snail (pFLAG-
-Arg mutation (pFLAG-Snail187R), and double mutation of Snail Lys146 and
ed Snail (left panel) or lysine-187-acetylated Snail (right panel) in 293T cells
ression vector. b-actin was a loading control.
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Figure 3. Acetylation of Snail Prevents the Assembly of the Snail Repressor Complex, and HDAC1/HDAC2 Deacetylates Snail
(A) Immunoprecipitation (IP)-western blot of 293T cells cotransfected with pHA-Ajuba, pFLAG-CBP, and pcDNA3-Snail. The protein lysates were immunopre-
cipitated and immunoblotted with indicated antibodies. IgG, immunoglobulin G; IB, immunoblot.
(B) Immunoprecipitation-western blot of FaDu cells. The lysates were immunoprecipitated and immunoblotted with the indicated antibodies.
(C) Immunoprecipitation-western blot of 293T cells stably transfected with WT Snail (pFLAG-Snail) or the non-acetylatable Snail mutant (pFLAG-Snail2R) with or
without co-transfection of pHA-CBP. The lysates were immunoprecipitated and immunoblotted with the indicated antibodies.
(D) ChIP and sequential ChIP in FaDu cells. The protein-DNA was cross-linked and sequentially immunoprecipitated by one or two antibodies as indicated.
The DNA fragments containing the Snail binding sites on the promoter of different genes (CDH1, IL8, and ERCC1) were amplified by PCR and analyzed by
electrophoresis.
(legend continued on next page)
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Figure 4. TNF-a-CBP Axis Promotes Snail
Acetylation
(A) Immunoprecipitation (IP)-western blot for
analyzing the interaction between Snail and WT
CBP, phosphomimetic CBP (EE-CBP), or non-
phosphorylatable CBP (AA-CBP). The 293T cells
were cotransfected with WT Snail (pFLAG-Snail)
and the indicated plasmids. IgG, immunoglobulin
G. IB, immunoblot.
(B) Immunoprecipitation-western blot for
analyzing acetylated Snail in 293T cells co-
transfected with WT CBP/EECBP/AACBP and
pFLAG-Snail.
(C) Luciferase reporter assay. The 293T cells
were cotransfected with the promoter reporter
construct (upper panel: pXP2-ERCC1; lower
panel, pXP2-IL8) and different expression vectors
as indicated. Data represent means ± SEM.
*p < 0.05; **p < 0.01.
(D) Immunoprecipitation-western blot for
analyzing the acetylated Snail in four cancer cell
lines (FaDu, OECM-1, CL1-1, and CL1-5) treated
with 20 ng/ml TNF-a for 8 hr or a vehicle control.
(E) Western blot for analyzing the phosphorylated
IKKa and acetylated Snail and immunoprecipita-
tion-western blot for detecting phosphorylated
CBP in FaDu cells treated with 20 ng/ml TNF-a for
8 hr or a vehicle control. b-actin was a loading
control for immunoblots.
(F) Western blot for detecting acetylated Snail in
MEFs from IKKa/, IKKb/, or IKKg/ mice
treated with 20 ng/ml murine TNF-a for 8 hr or a
vehicle control.
(G) Quantitative real-time PCR for analyzing the
messenger RNA (mRNA) level of ERCC1 and
IL8 in FaDu cells stably transfected with a WT
Snail (FaDu-Snail)/non-acetylatable Snail mutant
(FaDu-Snail2R) or an empty vector (FaDu-CDH)
and treated with 20 ng/ml TNF-a for 8 hr. Data
represent means ± SEM. *p < 0.05.
(H) Quantitative real-time PCR for analyzing the
expression of ERCC1 in HCT15-Snail versus
HCT15-control treated with different inhibitors.
C646 is a CBP/p300 inhibitor (6 mM for 8 hr). TNFI
is a TNFR inhibitor (30 mM for 8 hr), and etanercept
is a soluble receptor for neutralizing TNF-a
(25 mg/ml for 8 hr). Data represent means ± SEM.
**p < 0.01.
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Snail Acetylation Promotes Macrophage Recruitmentgroup of Snail-activated genes and the Snail-induced cytokine
change has not yet been exhaustively investigated. We first
investigated the paracrine effect of acetylated Snail-expressing(E) Quantitative ChIP in FaDu cells. The protein-DNA was crosslinked and immun
anti-acetylated Snail lysine 187 (right) antibody. The DNA fragments containing the
were amplified by quantitative PCR and presented as the percentage of input. D
(F) Immunoprecipitation-western blot for analyzing acetylated Snail in Snail-tran
control (Ctrl), a HDAC inhibitor TSA 5 nM for 8 hr, a SIRT1 inhibitor NAM 10 mM
(G) Immunoprecipitation-western blot for analyzing the acetylated Snail in Snail-t
was knocked down by two independent shRNA sequences. Transfection of the s
Snail is detected by immunoprecipitation-western blot or acetylated Snail-specifi
(H) In vitro deacetylation assay. The GST-Snail (purified from 293T cells cotransfe
HDAC1, HDAC2, or HDAC3 for 30 min then immunoblotted with the anti-acetylat
control for confirming the specific deacetylation effect of HDAC1/2 on Snail.
See also Figure S3.
540 Cancer Cell 26, 534–548, October 13, 2014 ª2014 Elsevier Inc.cancer cells. The results showed that the conditioned medium
from FaDu-Snail cells, but not from FaDu-Snail2R or FaDu-con-
trol cells, enhanced Snail acetylation (Figure 5C) and target geneoprecipitated by an anti-Snail (left), anti-acetylated Snail lysine 146 (middle), or
Snail binding sites on the promoter of different genes (CDH1, IL8, and ERCC1)
ata represents means ± SEM. *p < 0.05.
sfected 293T cells (upper) and FaDu-Snail cells (lower) treated with a vehicle
for 8 hr, or in combination.
ransfected 293T cells receiving shRNA against HDAC1 or HDAC2. Each target
crambled sequence (scr) was a control for shRNA experiment. The acetylated
c antibodies.
cted with pGST-Snail and pHA-CBP) was coincubated with indicated doses of
ed Snail lysine 146 and anti-acetylated Snail lysine 187 antibodies. HDAC3 is a
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Figure 5. TNF-a, CCL2, and CCL5 Are Downstream Targets of Snail
(A) A scatterplot showing the results of the cDNA microarray in FaDu-Snail versus FaDu-Snail2R.
(B) Left: a table summarizing the results of the cDNA microarray data analyzed by gene ontology. Right: a heatmap showing the differentially expressed genes
related to immune responses.
(C) Left: schema for representing the experiment procedure. Right: analyzing the acetylated in WT FaDu cells treated with the supernatant from FaDu-CDH,
FaDu-Snail, or FaDu-Snail2R by immunoprecipitation (IP)-western blot (upper panel) or the acetylated-Snail specific antibodies (lower panel). The fold change of
acetylated Snail was shown. CM, conditioned medium; IB, immunoblot.
(legend continued on next page)
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Snail Acetylation Promotes Macrophage Recruitmentexpression in WT FaDu cells (Figure 5D). To determine the major
cytokine genes regulated by Snail, a PCR array was performed in
FaDu-Snail versus FaDu-control cells and HT-29 cells receiving
small hairpin RNA (shRNA) against Snail or control. Ingenuity
pathway analysis (IPA) was used to narrow down the target
genes, and we validated the result in an independent cell line,
HCT-15 (Figure 5E; Figures S4B and S4C). A number of cytokine
genes were induced by Snail in the PCR array analysis (Table
S2). The expression and secretion of interleukin-6, an inflamma-
tory cytokine that plays an important role in cancer progression
(Guo et al., 2012) and has been shown to be upregulated by
Snail (Lyons et al., 2008), was increased in FaDu-Snail but not
in FaDu-Snail2R (Figure S4D). Here, we focused on TNF-a,
CCL2, and CCL5 because they are located in the center of the
signaling network from IPA analysis (Figure S4B), suggesting
their importance in the Snail-modulated cytokinome. Further-
more, TNF-a is critical for maintaining/amplifying Snail acetyla-
tion signal through a positive feedback loop. Ectopic Snail, but
not Snail2R, increased the expression of CCL2, CCL5, and
TNF-a (Figure 5F) and enhanced their secretion (Figure S4E).
Knocking down Snail repressed the expression of CCL2,
CCL5, and TNF-a (Figures S4F–S4I). Transfection of WT Snail,
but not Snail2R, increased the promoter activity of CCL2,
CCL5, and TNFA, and the coexpression of a phosphomimetic
CBP further augmented this effect (Figures 5G and 5H). A ChIP
assay confirmed the direct binding of Snail to the promoters of
these genes (Figure S4J). Mutation of the Snail acetylation sites
(Snail2R) or neutralization of TNF-a by etanercept abrogated the
expression of Snail target genes (Figure S4K).
We further examined whether the expression of TNFA/CCL2/
CCL5 is Snail dependent because they are known targets of
the TNF-a-NFkB pathway (Goldfeld et al., 1990; Ueda et al.,
1997; Wickremasinghe et al., 2004). Under TNF-a treatment,
the suppression of NFkB activity attenuated the expression of
CCND1, a known target gene of NFkB (Guttridge et al., 1999),
in both FaDu-Snail and FaDu-control cells (Figure S4L). How-
ever, inhibiting NFkB activity only partially abrogated the expres-
sion of CCL2, CCL5, and IL8 in FaDu-Snail cells (Figure S4M).
Knocking down endogenous Snail reduced the induction of
TNFA, CCL2, and CCL5 expression by TNF-a (Figure S4N).
These results suggest that CCL2, CCL5, and TNFA are target
genes that are activated by acetylated Snail. TNF-a and Snail
form a positive feedback loop that amplifies the signal.
Snail Acetylation Promotes the Recruitment of
Macrophages and Facilitates Tumor Progression
Next, we investigated the functional impact of Snail acetyla-
tion in cancer cells. Interestingly, we found that many Snail
target genes are chemoattractants for tumor-associated macro-(D) Quantitative real-time PCR for analyzing the expression of ERCC1and IL8 in F
mRNA, messenger RNA. Data represent means ± SEM. *p < 0.05; **p < 0.01.
(E) Schema for representing the strategy in mining candidate cytokine genes reg
(F) Western blot of TNF-a, CCL2, and CCL5 in FaDu-CDH versus FaDu-Snail ver
(G) Schematic representation of the organization of the promoter of TNFA, CCL2,
pGL-CCL2, and pGL-CCL5. TSS, transcriptional start site; E1, exon 1. The black
(H) Luciferase (Luc) reporter assays for analyzing the activity of the TNFA, CCL2,
empty vector (EV). b-gal, b-galactosidase. Data represent means ± SEM. *p < 0.
See also Figure S4 and Tables S1 and S2.
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TAMs (Azenshtein et al., 2002; Qian et al., 2011). Interleukin-8
(IL8) is the ligand of CXCR1 and CXCR2 (Loetscher et al.,
1994), which are highly expressed on the surface of M2 macro-
phages (Mantovani et al., 2002), and TAMs are considered to
have an M2-like phenotype (Biswas and Mantovani, 2010).
Therefore, we examined whether Snail-induced chemokine
secretion is critical for this effect. The results revealed that the
overexpression of Snail, but not of Snail2R, increased the che-
moattraction of FaDu cells to CD14+ monocytes (Figures 6A and
6B). The neutralization of Snail-induced cytokines (CCL2, CCL5,
or IL8) attenuated monocyte migration (Figure 6C). An increased
rapid recruitment of CD14+ human monocytes to the lungs was
observed in mice that were coinjected with FaDu-Snail cells
compared with mice that were coinjected with FaDu-Snail2R/
FaDu-control cells (Figure 6D). The conditioned medium from
FaDu-Snail cells, but not from FaDu-Snail2R/FaDu-control
cells, increased the expression of surface mannose receptors,
a marker of alternatively activated macrophages (Mantovani
et al., 2002), in both CD14+ monocytes and THP1 cells (Figures
S5A and S5B). We next examined the effect in vivo by implant-
ing the murine mammary carcinoma cells 4T1 that stably ex-
pressed WT Snail, Snail2R, or a control vector into the mam-
mary fat pads of BALB/c mice (Figure 6E). The majority of
the 4T1-Snail-formed tumors expressed higher levels of acety-
lated Snail than did the 4T1-control- or 4T1-Snail2R-formed
tumors (Figure S5C). The expression of Snail in 4T1 cells mildly
increased the tumor size/weight but significantly promoted
metastasis compared with the 4T1-Snail2R/4T1-control (Fig-
ures 6F–6H). Microscopically, the 4T1-Snail-formed tumors
had an increased infiltration by TAMs (Figure 6I) and microvas-
cular density (Figure 6J). The infiltrated TAMs primarily ex-
pressed arginase-1 (Figure S5D), a marker of alternatively
activated macrophages (Mantovani et al., 2002).
To confirm the critical role of TNF-a secretion by cancer cells
in Snail-mediated tumor progression, we generated murine
Snail-expressing LLC1 cells (LLC1-Snail) and knocked down
TNF-a in LLC1-Snail cells (Figure 7A). We inoculated the cells
into the subcutaneous area of Tnf/mice to prevent confound-
ing effects from host TNF-a and observed the impact of TNF-a
knockdown in Snail-mediated cancer progression and recruit-
ment of TAMs (Figure 7B). The overexpression of Snail in LLC1
cells resulted in increased tumor growth and promoted metas-
tasis (Figures 7C and 7D). LLC1-Snail-formed tumors had a
higher infiltration of TAMs (Figure 7E) and microvascular density
(Figure 7F), and the infiltrated TAMsweremostly arginase-1 pos-
itive (Figure S6). The knockdown of TNF-a in LLC1-Snail reduced
tumorigenesis, metastasis, TAM recruitment, and angiogenesis
(Figures 7C–7F; Figure S6).aDu cells treated with the conditioned medium from FaDu-CDH or FaDu-Snail.
ulated by Snail. qRT-PCR, quantitative real-time PCR.
sus FaDu-Snail2R. The fold change of target proteins was shown.
and CCL5, and the corresponding luciferase reporter constructs pXP2-TNFA,
bars indicate the E-boxes, which are the putative binding sites of Snail.
and CCL5 promoter constructs in 293T cells cotransfected with EECBP or an
05.
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Figure 6. Snail Acetylation Promotes the Recruitment of TAMs and Tumor Progression
(A) Schema for representing the monocytes migration experiment.
(B) Transwell migration assay of human CD14+ monocytes attracted by FaDu-CDH, FaDu-Snail, or FaDu-Snail2R. Data represent means ± SEM. *p < 0.05.
(C) Transwell migration assay of monocytes attracted by FaDu-Snail. Different neutralizing antibodies were added as indicated. Data represent means ± SEM.
*p < 0.05. IgG, immunoglobulin G.
(D) In vivo macrophages rapid recruitments assay. Upper, schema for animal experiment; lower, quantification of the recruited PKH26-labeled macrophages in
lungs of the mice 30 hr after monocytes injection. n = 5 for each group. Data represent means ± SEM. *p < 0.05.
(E–J) Orthotopic imaplantation assay. The 4T1 cells expressing WT Snail, nonacetylatable Snail (Snail2R), or a control vector were inoculated into the mammary
fat pad of the BALB/c mice. The tumor volume was measured regularly, and the mice were sacrificed after 24 days. n = 6 for each group. (E) Left: western blot to
confirm the expression of ectopic WT Snail and Snail2R in 4T1 cells. Right: schema of the experiment. (F) The photo of orthotopic tumors. (G) The tumor volume
(left) and tumor weight (right) of orthotopic tumors. Data represent means ± SEM. *p < 0.05. (H) Representative photos of the lungs of mice implanted with
indicated cells. The arrows indicate themetastatic tumors in lung. The numbers in the parentheses indicate themetastatic-tumor-formingmice/total mice in each
(legend continued on next page)
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Snail Acetylation Promotes Macrophage RecruitmentSnail Acetylation Is Associated with TAM Recruitment
and Poor Prognosis of Head and Neck Cancer Patients
Finally, we confirmed the proposed mechanism in public array
database and human cancer specimens. First, we investigated
the correlation between SNAI1 and the target genes in the public
database. In array data from the NCI-60 panel, the level of SNAI1
significantly correlated with the expression levels of CCL2 and
CCL5, while SNAI1 was inversely correlated with CDH1 (Fig-
ure S7A). In data obtained from ONCOMINE (Rhodes et al.,
2004), the expression patterns of SNAI1, CCL2, and CCL5 for
head and neck cancers originating from different sites were
similar (Figure S7B). Next, we confirmed the correlation and clin-
ical significance of Snail acetylation and TAMs in human cancer
specimens. A significant correlation between the percentage of
acetylated Snail (detected by the PLA) and the number of
TAMs was shown in tumor tissue samples from patients with
head and neck cancers (Figures 8A and 8B; Table S3). The
expression of acetylated Snail (detected by an anti-acetylated
Snail Lys187 antibody) was correlated with increased infiltration
of TAMs in head and neck cancers (Figure 8C; Table S4) and in
lung cancers (Figure S7C). A concomitant increase in acetylated
Snail and TAM numbers was correlated with a shorter progres-
sion-free survival in head and neck cancer patients (Figure 8D).
DISCUSSION
Several transcriptional factors have been known to function as
both a repressor and an activator by associating with different
coregulators, such as the nuclear receptors (McKenna and
O’Malley, 2002) and the MEF2 family of transcriptional factors
(McKinsey et al., 2002), which extends their functional flexibility.
Lysine acetylation of the histone and nonhistone proteins plays
a crucial role in regulating fundamental biological processes,
including gene expression (Choudhary et al., 2009). A great
example is the p53 acetylation in target gene regulation (Brooks
andGu, 2011). Here, we demonstrate that the acetylation of Snail
affects its association with different coregulators, thereby deter-
mining it as an activator or a repressor. Interestingly, acetylated
Snail can act either as an activator (e.g., in ERCC1) or as a
coactivator (e.g., in FN1), which greatly extends the function of
Snail during cancer metastasis. Another interesting question is
whether Snail acetylation affects the EMT phenotype, given
that acetylated Snail prohibits repressor complex formation.
Our ChIP experiments showed that acetylated Snail binds to
the promoters of activated target genes and that nonacetylated
Snail binds to the promoters of repressed target genes simulta-
neously in the same cells. Furthermore, Snail also induces the
expression of Zeb1, which is another major EMT inducer that
directly represses E-cadherin expression. This finding may
explain why cancer cells expressing acetylatable Snail are still
capable of repressing E-cadherin. Here, we also found that Snail
acetylation more prominently promotes tumor metastasis
compared with primary tumor growth. The possible explanation
is that Snail activation may induce cell cycle arrest (Vega et al.,group. (I) Upper: IHC of F4/80 for showing the recruitments of macrophages in ort
per high power field (HPF). Data represent means ± SEM. *p < 0.05. (J) Upper: IH
vessels per HPF. Data represent means ± SEM. *p < 0.05.
See also Figure S5.
544 Cancer Cell 26, 534–548, October 13, 2014 ª2014 Elsevier Inc.2004; Hu et al., 2010), which could attenuate its impact on pri-
mary tumor growth.
In this study, we identified that TNF-a is the crucial exogenous
stimulus for Snail acetylation and that TNF-a and Snail form a
positive feedback loop to amplify the signal. The importance of
TNF-a in triggering EMT of cancer cells has been shown in
previous studies (Wu and Zhou, 2010). TNF-a induces EMT
through the NFkB-mediated transcription of TWIST1 (Li et al.,
2012) and stabilizes Snail through CSN2 (Wu et al., 2009).
Together with our current findings and those obtained in previ-
ous studies, we suggest that TNF-a has dual effects on Snail:
TNF-a stabilizes Snail to increase its amount and promotes Snail
acetylation to activate the transcription of target genes. How-
ever, although few studies have utilized etanercept, a decoy re-
ceptor of TNF-a, in cancer treatment (Wu et al., 2013), the overall
benefit of blocking TNF-a is minimal (Zidi et al., 2010). In this
study, we showed that etanercept abrogates acetylated Snail-
induced target gene transcription and that IKKa is crucial for
TNF-a-mediated Snail acetylation. Therefore, we suggest that
understanding the activity of the TNF-a-IKKa-acetylated Snail
pathway may improve the effectiveness of using etanercept in
cancer treatment.
TAMs mainly have a phenotype resembling the alternatively
activated M2 macrophages (Biswas and Mantovani, 2010). In
this study, we show that the cancer cells expressing acetylated
Snail not only recruit TAMs by secretingCCL2, CCL5, and IL8 but
also induce macrophages to exhibit an M2-like phenotype (ex-
pressing the mannose receptor and promoting angiogenesis).
However, the expression of cytokines for the M2 polarization of
macrophages, e.g., interleukin 10 and interleukin 13, was not
elevated in Snail-expressing cancer cells (Table S2). Whether
these cancer cells induce an M2-like polarization through
nonclassical M2-polarizing cytokines or through recruiting/acti-
vating of other immune cells, e.g., Th2 cells (Stein et al., 1992),
is unknown and needs to be further addressed.
In conclusion, our study discovered that cancer cells contain-
ing acetylated Snail modulate the cytokinome in the tumor
microenvironment. This finding extends the repertoire of roles
for Snail. Therefore, we have contributed to a comprehensive
understanding of Snail’s functions in the metastatic process,
including its role as a transcriptional activator for inducing
cytokine expression in the tumor microenvironment and as a
transcriptional repressor for suppressing adherent protein
expression in driving cancer cell migration.EXPERIMENTAL PROCEDURES
In Vitro Acetylation and Deacetylation Assay
The HAT domain of the p300/CBP protein was purchased from the Upstate
Company (#14-418, Merck KGaA). The in vitro acetylation assay was per-
formed using biotin-tagged peptides that contain a portion of Snail around
lysine 146 (QLAQLSEAKDLQAR) or lysine 187 (VCGTCGKAFSRPW). Peptides
in which lysine was replaced with the nonacetylatable aa arginine (QLAQL
SEARDLQAR, VCGTCGRAFSRPW) were used as controls in the experiment.
In the standard assay, 0.5 mg peptide, 0.5 mg of the HAT domain of thehotopic tumors. Scale bar, 50 mm. Lower: quantification of F4/80-positive cells
C of CD31 in orthotopic tumors. Scale bar, 50 mm. Lower: quantification of the
A B
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Figure 7. Tumor-Secreted TNF-a Is Critical for Snail-Induced Tumor Progression
(A) Western blot for confirming the expression of Snail and TNF-a in the LLC1 cells expressing WT murine Snail (LLC1-Snail) or a control vector (LLC1-Ctrl), and
the LLC1-Snail cells receiving shRNA against murine TNF-a or a control vector (pLKO).
(B) Schema of the experiment. The LLC1 cells were inoculated into subcutaneous area of the Tnf/mice (n = 6 for each group). The tumor volumewasmeasured
regularly and the mice were sacrificed after 24 days.
(C) Left: photos of LLC1-formed tumors. Right: the tumor volume and tumor weight. Data represent means ± SEM. The p value is shown in each panel.
(legend continued on next page)
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A B
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Figure 8. Clinical Significance of Snail Acet-
ylation in Head and Neck Cancer Patients
(A) PLA for detecting acetylated Snail (left) and IHC
for analyzing CD68+ (middle) or CD163+ (right)
macrophages in head and neck cancer patients.
The arrows indicate the representative PLA-posi-
tive signals. Case 1 is a representative case with
increased acetylated Snail and CD68+/CD163+
macrophages. Case 2 is a representative case
with low acetylated Snail and macrophage re-
cruitments. Scale bars: for PLA photo, 20 mm; for
CD68/CD163 IHC, 200 mm.
(B) The box plot for showing the percentage of
PLA-positive cells in CD68low versus CD68high
(upper panel) and CD163low versus CD163high
(lower panel) head and neck cancer samples (n =
15). The p value was shown in each panel. The box
plots represent sample maximum (upper end of
whisker), upper quartile (top of box), median (band
in the box), lower quartile (bottom of box), and
sample minimum (lower end of whisker).
(C) Representative results of immunohistochemistry
using the antibody against acetylated Snail lysine
187 or a macrophage marker CD163 in head and
neck cancer samples. Case 1, a representative case
of increased acetylated Snail in cancer cells and tu-
mor-associated macrophages. Case 2, a represen-
tative case of low level of acetylated Snail in cancer
cells and few macrophages. Scale bars, 200 mm.
(D) A Kaplan-Meier analysis of the progression-
free survival in 82 head and neck cancer patients.
The p value is shown in the panel.
See also Figure S7 and Tables S3 and S4.
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Snail Acetylation Promotes Macrophage Recruitmentp300/CBP protein, 1 mg acetyl-CoA (No. A2181, Sigma-Aldrich), and 4 ml 53
HAT assay buffer (250 mM Tris-HCl, pH 8.0, 50% glycerol, 0.5 mM EDTA,
5 mM dithiothreitol) were incubated for 30 min. The reaction products were
loaded onto the nitrocellulose paper and blottedwith an anti-acetyl-lysine anti-
body. The in vitro deacetylation assay was performed by incubating HDAC1,
HDAC2, and HDAC3 (Nos. 31342, 31343, and 31349, respectively; Active
Motif) with glutathione S-transferase (GST)-purified Snail from 293T cells co-
transfected with pHA-CBP and pGST-Snail. In this assay, 0.25 or 0.5 mg
HDAC and 0.5 mg GST-Snail were incubated with deacetylation buffer
(10 mM Tris-HCl, pH 8.0, 100 mM NaCl) for 30 min. The reaction products
were subjected to western blot analysis and detected using the anti-acetylated
lysine 146 and lysine 187 Snail antibodies.
Animal Experiments
The animal experiments were approved by the Institutional Animal Care
and Utilization Committee of Taipei Veterans General Hospital (case no.
IACUC2013-038). The animal experiments include three parts. The first one
is the in vivo macrophages recruitment assay. Human CD14+ monocytes
were incubated with 2 mM PKH26 for 5 min at room temperature, followed
by the addition of an equal volume of serum to stop the reaction. Each nonob-
ese diabetic-severe combined immunodeficiency mouse received an injection
of 1 3 106 FaDu-CDH or FaDu-Snail or FaDu-Snail2R cells (n = 5 for each
group). After 6 hr, 2 3 105 PKH26-labeled monocytes were injected into the
tail veins of the same mice; then the mice were sacrificed, and the lungs(D) Representative photos of the lungs of mice implanted with indicated cells. The
indicate the metastatic-tumor-forming mice/total mice in each group.
(E) Left: IHC of F4/80 for showing the recruitments of macrophages in LLC1-forme
power field (HPF). Data represent means ± SEM. The p value is shown in the cor
(F) Left: IHC of CD31 in LLC1-formed tumors. Scale bar, 50 mm. Right: quantificatio
each panel.
See also Figure S6.
546 Cancer Cell 26, 534–548, October 13, 2014 ª2014 Elsevier Inc.were harvested 30 hr following the monocyte injection. The lungs were trypsi-
nized with 0.25% trypsin and 2.5mg/ml collagenase I for 45min at 37C. Every
5–8 min during this incubation, the tube was gently agitated for a few seconds.
After 45 min of incubation, the tube was then vigorously shaken for 30 s to
dissolve the lung, and the resulting tissue/cell suspension was filtered through
a 70 mm strainer. The recruited macrophages were quantified by flow cytom-
etry to detect PKH26-labeled cells. The second experiment is the orthotopic
implantation assay. 4T1 cells expressingWT ormutant Snail or a control vector
were injected into the mammary fat pad of BALB/c mice (n = 6 for each group).
The size of the orthotopic tumors was measured regularly throughout the
experiment. The mice were sacrificed 24 days after tumor inoculation, and
the orthotopic tumors were harvested for measuring weight, TAM infiltrations,
and microvascular densities (MVDs). The development of metastatic lung
tumors was observed in each group. The third experiment is implanting
LLC1 cells into Tnf/ mice to observe the effect of tumor-secreted TNF-a
on cancer metastasis. The Tnf/ mice have previously been described (Pas-
parakis et al., 1996; Chio et al., 2012). For mouse typing, genomic DNA sam-
ples were prepared from tail tissues harvested from the mice and genotyped
by PCR using specific primer sets. The LLC1 cells were stably transfected
withmurine Snail or a control vector, and the LLC1-Snail cells were transfected
with a shRNA against Tnf or a control sequence. Then, the cells were inocu-
lated into the subcutaneous area of mice (n = 6 for each group). The size of
the tumors was measured regularly. The mice were sacrificed 24 days after
tumor inoculation, and the tumors were harvested to measure the weight,arrows indicate themetastatic tumors in lungs. The numbers in the parentheses
d tumors. Scale bar, 50 mm. Right: quantification of F4/80-positive cells per high
responding panels.
n of the vessels per HPF. Data representmeans ± SEM. The p value is shown in
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Snail Acetylation Promotes Macrophage RecruitmentTAMs infiltration, and MVDs. The development of metastatic lung tumors was
observed in each group.
Patient Samples
This study was approved by the Institutional Review Board of Taipei Veterans
General Hospital (case no. VGHIRB-2013-04-035B), and the informed con-
sents have been obtained from all patients. We used three sets of samples
to investigate the correlation between acetylated Snail and TAM infiltration.
The first group, which contained 15 paraffin-embedded head and neck cancer
samples from patients receiving treatment at the Department of Otolaryn-
gology of Taipei Veterans General Hospital, was used for the PLA and
CD163 staining. The characteristics of the 15 patients are listed in Table S3,
and the results are shown in Figures 7A and 7B. The second group contained
samples from 82 head and neck cancer patients, and the samples were used
for immunohistochemistry (IHC) using the antibody against acetylated Snail
lysine 187 and CD163. The characteristics of the 82 patients are listed in Table
S4, and the results are shown in Figures 7C and 7D. The third group included
ten non-small-cell lung cancer samples. A representative IHC result is shown
in Figure S6C.
Statistical Analysis
A two-tailed independent Student’s t test was used to compare the continuous
variables between the two groups. The chi-square test was applied to
compare dichotomous variables. The Kaplan-Meier estimation and the log-
rank test were used to compare survival between the patient groups. All the
statistical data were derived from at least two biological independent experi-
ments, and each experiment contained two technical replicates. The level of
statistical significance was set at pG 0.05 for all tests.
ACCESSION NUMBERS
The data sets of the cDNA microarray for FaDu-CDH versus FaDu-Snail and
FaDu-Snail2R were deposited at Gene Expression Omnibus with the acces-
sion number GSE58592.
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